Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Pre-Tax Profit Margin 2011-2024 | ZTS

Current and historical pre-tax profit margin for Zoetis (ZTS) from 2011 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Zoetis pre-tax profit margin for the three months ending September 30, 2024 was .
  
Zoetis Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $9.15B $3.05B 33.34%
2024-06-30 $8.92B $2.89B 32.46%
2024-03-31 $8.73B $2.99B 34.19%
2023-12-31 $8.54B $2.94B 34.36%
2023-09-30 $8.37B $2.88B 34.38%
2023-06-30 $8.22B $2.83B 34.40%
2023-03-31 $8.09B $2.63B 32.44%
2022-12-31 $8.08B $2.66B 32.87%
2022-09-30 $8.01B $2.57B 32.10%
2022-06-30 $8.00B $2.56B 32.05%
2022-03-31 $7.89B $2.53B 32.04%
2021-12-31 $7.78B $2.49B 32.00%
2021-09-30 $7.62B $2.40B 31.54%
2021-06-30 $7.41B $2.34B 31.57%
2021-03-31 $7.01B $2.19B 31.18%
2020-12-31 $6.68B $2.00B 29.90%
2020-09-30 $6.54B $2.01B 30.77%
2020-06-30 $6.34B $1.94B 30.66%
2020-03-31 $6.34B $1.92B 30.24%
2019-12-31 $6.26B $1.80B 28.77%
2019-09-30 $6.15B $1.78B 28.98%
2019-06-30 $6.05B $1.67B 27.65%
2019-03-31 $5.91B $1.65B 27.97%
2018-12-31 $5.83B $1.69B 29.01%
2018-09-30 $5.72B $1.70B 29.75%
2018-06-30 $5.59B $1.70B 30.37%
2018-03-31 $5.44B $1.61B 29.49%
2017-12-31 $5.31B $1.53B 28.74%
2017-09-30 $5.12B $1.33B 25.88%
2017-06-30 $5.02B $1.25B 24.83%
2017-03-31 $4.96B $1.23B 24.87%
2016-12-31 $4.89B $1.23B 25.12%
2016-09-30 $4.89B $1.07B 21.82%
2016-06-30 $4.86B $1.01B 20.71%
2016-03-31 $4.83B $0.65B 13.41%
2015-12-31 $4.77B $0.55B 11.44%
2015-09-30 $4.81B $0.63B 13.12%
2015-06-30 $4.81B $0.60B 12.40%
2015-03-31 $4.79B $0.82B 17.18%
2014-12-31 $4.79B $0.82B 17.14%
2014-09-30 $4.72B $0.79B 16.76%
2014-06-30 $4.61B $0.74B 16.00%
2014-03-31 $4.57B $0.73B 15.87%
2013-12-31 $4.56B $0.69B 15.13%
2013-09-30 $4.48B $0.64B 14.23%
2013-06-30 $4.40B $0.67B 15.14%
2013-03-31 $4.38B $0.73B 16.69%
2012-12-31 $4.34B $0.71B 16.37%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $76.797B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $66.907B 26.06
Takeda Pharmaceutical (TAK) Japan $42.351B 8.81
Sandoz Group AG (SDZNY) Switzerland $20.614B 0.00
Merck (MKKGY) Germany $20.007B 17.92
Astellas Pharma (ALPMY) Japan $17.699B 16.30
United Therapeutics (UTHR) United States $16.641B 16.37
Summit Therapeutics (SMMT) United States $15.958B 0.00
Neurocrine Biosciences (NBIX) United States $15.256B 40.40
Shionogi (SGIOY) Japan $12.454B 12.48
Orion OYJ (ORINY) Finland $7.529B 21.17
Madrigal Pharmaceuticals (MDGL) United States $7.117B 0.00
Stevanato Group S.p.A (STVN) Italy $6.493B 42.04
Corcept Therapeutics (CORT) United States $6.447B 48.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.192B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.937B 7.84
Grifols, S.A (GRFS) Spain $4.813B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.652B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.858B 12.95
Recursion Pharmaceuticals (RXRX) United States $2.798B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.705B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $2.236B 0.00
Soleno Therapeutics (SLNO) United States $2.128B 0.00
Hypermarcas (HYPMY) Brazil $1.926B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.920B 0.00
Indivior (INDV) United States $1.675B 6.83
BioCryst Pharmaceuticals (BCRX) United States $1.661B 0.00
Evotec AG (EVO) Germany $1.495B 0.00
Guardian Pharmacy Services (GRDN) United States $1.413B 0.00
ARS Pharmaceuticals (SPRY) United States $1.392B 0.00
Dyne Therapeutics (DYN) United States $1.378B 0.00
Xencor (XNCR) United States $1.318B 0.00
Ardelyx (ARDX) United States $1.298B 0.00
Ocular Therapeutix (OCUL) United States $1.233B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 0.00
Harrow (HROW) United States $1.152B 0.00
Collegium Pharmaceutical (COLL) United States $1.046B 5.71
Enliven Therapeutics (ELVN) United States $1.019B 0.00
Bioventus (BVS) United States $0.851B 26.90
Relay Therapeutics (RLAY) United States $0.750B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.738B 0.00
Cronos Group (CRON) Canada $0.719B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Verve Therapeutics (VERV) United States $0.652B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.595B 0.00
Xeris Biopharma Holdings (XERS) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
Elite Pharmaceuticals (ELTP) United States $0.500B 0.00
Altimmune (ALT) United States $0.494B 0.00
Organogenesis (ORGO) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.474B 0.00
ProKidney (PROK) United States $0.467B 0.00
Savara (SVRA) United States $0.458B 0.00
OmniAb (OABI) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.447B 5.22
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Oruka Therapeutics (ORKA) United States $0.422B 0.00
Zevra Therapeutics (ZVRA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 160.64
Esperion Therapeutics (ESPR) United States $0.372B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.308B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.277B 16.46
CytoDyn (CYDY) United States $0.255B 0.00
Heron Therapeutics (HRTX) United States $0.254B 0.00
Avita Medical (RCEL) United States $0.246B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.237B 0.00
Larimar Therapeutics (LRMR) United States $0.237B 0.00
4D Molecular Therapeutics (FDMT) United States $0.231B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Inhibikase Therapeutics (IKT) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Acrivon Therapeutics (ACRV) United States $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.172B 0.00
Lyell Immunopharma (LYEL) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Nanobiotix S.A (NBTX) France $0.163B 0.00
Silence Therapeutics (SLN) United Kingdom $0.157B 0.00
Nektar Therapeutics (NKTR) United States $0.154B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.117B 0.00
Inotiv (NOTV) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
Protara Therapeutics (TARA) United States $0.093B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Journey Medical (DERM) United States $0.082B 0.00
AleAnna (ANNA) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.75
Avalo Therapeutics (AVTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
AlloVir (ALVR) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
BioVie (BIVI) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mannatech (MTEX) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00